Investment Summary

Ault Global Invests In Adtech Pharma

On June 28, 2021, Ault Global invested in life science company Adtech Pharma

Investment Highlights
  • This is Ault Global’s 1st transaction in the Life Science sector.
  • This is Ault Global’s 1st transaction in the United States.

Investment Summary

Date 2021-06-28
Target Adtech Pharma
Sector Life Science
Investor(s) Ault Global
Deal Type Stake Purchase

Target

Adtech Pharma

United States
Adtech Pharma is a biotech firm that has developed a novel formulation of a sole-sourced synthetic cannabinoid therapeutic targeting glaucoma.

Search 214,557 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Ault Global

Las Vegas , Nevada, United States

Category Company
Founded 1969
Sector Diversified
Employees144
Revenue 24M USD (2020)
DESCRIPTION

Ault Global is a diversified holding company pursuing growth by acquiring undervalued businesses and disruptive technologies with a global impact. Through its wholly and majority-owned subsidiaries and strategic investments, the Company provides mission-critical products that support a diverse range of industries, including defense/aerospace, industrial, automotive, telecommunications, medical/biopharma, and textiles. Ault Global was founded in 1969 and is based in Las Vegas, Nevada.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
Country: United States M&A 1 of 1
Year: 2021 M&A 1 of 1